SCHEMBL30285449

SCHEMBL30285449

CS(=O)(=O)c1c(Oc2cccc(-c3ncc(C(O)c4ccccc4)[nH]3)c2)c(F)cc2[nH]ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.37
▸ BACE2 Q9Y5Z0 3/20 0.37
▸ GRIN2D O15399 3/20 0.34
▸ GRIN3B O60391 3/20 0.34
▸ GRIN1 Q05586 3/20 0.34
▸ GRIN2A Q12879 3/20 0.34
▸ GRIN2B Q13224 3/20 0.34
▸ GRIN2C Q14957 3/20 0.34
▸ GRIN3A Q8TCU5 3/20 0.34
▸ NR1H2 P55055 3/20 0.33
▸ NR1H3 Q13133 2/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ SDHB P21912 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ GCK P35557 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29336583 1.00 BACE1 (0.37) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL29336940 0.90 BRD4 (0.32) BRD4GCKPTGS2
SCHEMBL30285454 0.90 BRD4 (0.32) BRD4GCKPTGS2
SCHEMBL29336584 0.90 BACE1 (0.36) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL30285506 0.90 BACE1 (0.36) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL30285407 0.85 GRIN2D (0.33) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL29336768 0.85 GRIN2D (0.33) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL29336772 0.83 PIN1 (0.36) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL30285518 0.83 PIN1 (0.36) BACE1BACE2GRIN2DGRIN3BGRIN1
SCHEMBL29336566 0.82 KDM4E (0.35) BACE1BACE2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396176-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2024-07-10 — — EP disclosed
WO-2023034946-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2023-03-09 — — WO disclosed
Send feedback